Cytomegalovirus glycoprotein B-specific antibody analysis using electrochemiluminescence detection-based techniques

Area of Science:

• Biochemistry
• Immunology
• Analytical Chemistry

Background:

• Cytomegalovirus (CMV) infection is a significant concern, particularly in immunocompromised individuals.
• Neutralizing antibodies targeting CMV glycoprotein B (gB) are crucial for controlling viral infection.
• Accurate measurement of seroreactivity against CMV gB epitopes is essential for diagnosis and monitoring.

Purpose of the Study:

• To develop and validate a sensitive electrochemiluminescence (ECL) assay for quantifying seroreactivity against CMV neutralization epitopes on glycoprotein B.
• To establish a versatile assay strategy for reliable determination of anti-CMV gB antibody levels.

Main Methods:

• Utilized an electrochemiluminescence (ECL) technique for assay development.
• Employed indirect binding assays to detect antibodies.
• Developed strategies for sample dilution using a monoclonal antibody-based standard.

Main Results:

• Achieved versatile and sensitive assay strategies for determining seroreactivity against CMV gB epitopes.
• Demonstrated wide linear assay ranges in indirect binding assays.
• Showcased simplified quantitative analytical assessments through parallel dilution of serum samples with a standard.

Conclusions:

• The developed ECL assay provides a sensitive and versatile platform for assessing CMV seroreactivity.
• The assay's design simplifies quantitative analysis, facilitating clinical and research applications.
• This method aids in understanding the immune response to CMV glycoprotein B.